Proxy Results (Form 8-K)

Item 5.07. Submission of Matters to a Vote of Security Holders.

On October 10, 2025, Picard Medical, Inc. (the "Company") held a special meeting of stockholders (the "Special Meeting") in accordance with the Notice of Special Meeting of Stockholders (the "Proxy Statement") dated September 29, 2025 filed with the Securities and Exchange Commission (the "Commission") and sent to stockholders of record as of September 16, 2025 (the "Record Date").

As of the Record Date, there were 73,701,176 shares of common stock, par value $0.0001 per share (the "Common Stock"), outstanding and entitled to vote at the Special Meeting. At the Special Meeting, a total of 54,377,330 shares of the Company's Common Stock were represented in person or by proxy, constituting a quorum.

Proposal. Approval of an Amendment to the Company's 2021 Equity Incentive Plan

At the Special Meeting, the Company's stockholders approved an amendment to the Company's 2021 Equity Incentive Plan (the "Amended Incentive Plan") to (i) increase the aggregate number of shares of Common Stock available under the 2021 Equity Incentive Plan to a total of 18,000,000 shares, (ii) include warrant as a type of awards issuable under the Amended Incentive Plan, and (iii) to ratify the 2021 Equity Incentive Plan. The voting results to approve the Amended Incentive Plan were as follows: